Considerations for Clinical Studies in Migraine Prophylaxis and Treatment
Recent medical advancements have improved the treatment of people with migraine, a disabling neurological disorder that compromises quality of life for a predominantly female population, but more can be done to prevent migraine and treat those suffering from the condition. Clinical trials in migraine rely heavily on patient-reported outcomes data, therefore, steps need to be taken to properly train and engage trial participants.
As a CRO committed to improving healthcare outcomes for women, Health Decisions is determined to advance and accelerate the clinical development of new treatment options for migraine sufferers. Drawing from past experience in central nervous system studies, Health Decisions determines appropriate solutions based on the unique operational needs of every trial in order to maximize efficiency.
Download this fact sheet to review Health Decisions’ top considerations for addressing operational issues and mitigating risks in migraine trials.